PubMed Health⌕ Search

Biomedical subjects

I Dissing

Publications and source records attributed to I Dissing.

22 records · Page 2Linked to original sources

Osteosarcoma of the metatarsal bones. Review of the literature and report of a case.

A case of osteosarcoma affecting the third metatarsal bone is submitted. Below-knee amputation was performed, but the patient developed pulmonary metastases and died 1 year after the operation. The six cases of osteosarcoma in the metarsal bones published so far are reviewed. The prognosis for cases with this localization does not appear to differ from that for osteosarcoma in general.

Adult↗

Numerical assessment of bone scintigraphy in primary bone tumors and tumor-like conditions.

Fifty-four tumors or tumor-like conditions in bone were studied by numerically assessed 99m-technetium polyphosphate scintigraphy. The uptake was expressed as a ratio of the uptake in the tumor region to the uptake in a corresponding region in the contralateral part of the body. In the malignant tumors there was marked variation in the uptake within each individual tumor group, a variation that rendered a differential diagnosis impossible. In general, the uptake was fairly high in malignant tumors and lower in benign ones. A ratio below 1.5 suggested the likelihood that the lesion was benign. The ratios also varied considerably with the site of the tumor and the patients' ages. Relatively low ratios were found for tumors of the trunk and for juxta-articular tumors in children, whereas higher and more varied ratios were observed in tumors of the peripheral skeleton in adults. It is concluded that numerically assessed scintigraphy is not a useful supplement to other methods used for diagnosing bone tumors.

Adolescent↗

Metastasis from an unknown tumour.

A total of 121 patients were treated under the diagnosis: metastasis from an unknown primary tumour; 99 were irradiated. In 46 cases the primary tumour was detected from 6 months to 10 years after the primary treatment. The 3-year survival was 28.9 per cent, the 5-year 17.4 per cent and for 10 years or longer (up to 14 years) 9.1 per cent, after the primary treatment. The prognosis is correlated to the size of the metastases, their site and also their microscopic appearances.

Adult↗